Suscribirse

Quality Improvement of Staphylococcus aureus Bacteremia Management and Predictors of Relapse-free Survival - 15/01/16

Doi : 10.1016/j.amjmed.2015.09.016 
Jennifer Townsend, MD a, , Jamie Pelletier, MPH b, Gail Peterson, MD c, Susan Matulevicius, MD, MSCS c, Pranavi Sreeramoju, MD, MPH a, d
a Division of Internal Medicine–Infectious Diseases, University of Texas Southwestern, Dallas 
b Department of Epidemiology, University of Texas Health Science Center School of Public Health, Dallas Campus 
c Division of Internal Medicine–Cardiology, University of Texas Southwestern, Dallas 
d Division of Clinical Quality Management, Parkland Health and Hospital System, Dallas, Texas 

Requests for reprints should be addressed to Jennifer Townsend, MD, Division of Infectious Diseases, Johns Hopkins Bayview Medical Center, 5200 Eastern Avenue, MFL Center Tower, #381, Baltimore, MD 21224.

Abstract

Purpose

The purpose of this study is to improve the quality of care and patient outcomes for Staphylococcus aureus bacteremia.

Methods

A quasi-experimental pre- and postintervention study design was used to compare process and clinical endpoints before and after a quality-improvement initiative. All inpatients >18 years of age with a positive blood culture for S. aureus during the specified pre- and postintervention period with clinical information available in the electronic medical record were included. An institutional protocol for the care of patients with S. aureus bacteremia was developed, formalized, and distributed to providers using a pocket card, an electronic order set, and targeted lectures over a 9-month period.

Results

There were 167 episodes of S. aureus bacteremia (160 patients) identified in the preintervention period, and 127 episodes (123 patients) in the postintervention period. Guideline adherence improved in the postintervention period for usage of transesophageal echocardiogram (43.9% vs 20.2%, P <.01) and adequate duration of intravenous therapy (71% vs 60%, P = .05). In a multivariate Cox proportional hazard model, the variables associated with increased relapse-free survival were postintervention period (hazard ratio [HR] 0.48; confidence interval [CI], 0.24-0.95; P .035) and appropriate source control (HR 0.53; CI, 0.24-0.92; P .027). Regardless of intervention, presence of cancer was associated with an increased risk of relapse or mortality at 90 days (HR 2.88; P <.0001; CI, 1.35-5.01).

Conclusion

A bundled educational intervention to promote adherence to published guidelines for the treatment of S. aureus bacteremia resulted in a significant improvement in provider adherence to guidelines as well as increased 90-day relapse-free survival.

El texto completo de este artículo está disponible en PDF.

Keywords : Bacteremia/drug therapy, Methicillin resistance, Staphylococcal infections/drug therapy, Staphylococcal infections/microbiology, Quality control


Esquema


 Funding: No direct funding was received. In-kind support was received from the University of Texas Southwestern Division of Internal Medicine–Infectious Diseases, and Parkland Health and Hospital System, Dallas, TX.
 Conflict of Interest: No authors had any conflicts of interest related to the project.
 Authorship: All authors had access to the data, made intellectually significant contributions to the project, and had a role in writing the manuscript.


© 2016  Elsevier Inc. Reservados todos los derechos.
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Vol 129 - N° 2

P. 195-203 - février 2016 Regresar al número
Artículo precedente Artículo precedente
  • Prevalence and Significance of Unrecognized Renal Dysfunction in Patients with Acute Coronary Syndrome
  • Zach Rozenbaum, Avi Leader, Yoram Neuman, Meital Shlezinger, Ilan Goldenberg, Morris Mosseri, David Pereg
| Artículo siguiente Artículo siguiente
  • Mindfulness-based Stress Reduction in Addition to Usual Care Is Associated with Improvements in Pain, Fatigue, and Cognitive Failures Among Veterans with Gulf War Illness
  • David J. Kearney, Tracy L. Simpson, Carol A. Malte, Benjamin Felleman, Michelle E. Martinez, Stephen C. Hunt

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.

¿Ya suscrito a @@106933@@ revista ?

@@150455@@ Voir plus

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.


Todo el contenido en este sitio: Copyright © 2026 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.